Best Mark Bender Podcasts (2025)

1
Investing in Impact: How Healthcare Innovation Can Transform Patient Outcomes with Sam Libby 35:06

Play Pause

29d ago35:06

35:06

In this episode, our guest is Sam Libby, President and Managing Director of TCB Capital Advisors. Sam's long-standing career in healthcare investment banking has seen him lead over 30 impactful transactions, totaling more than $20 billion. His dedication to healthcare is rooted in a personal connection, being the son of two therapists, which has gi…

1
Kevin Caldwell, Ossium Health CEO, on Cell Therapy, Vertical Integration & Immune Healthspan 36:28

1M ago36:28

36:28

Synopsis: From stargazing in rural Tennessee to reimagining the future of immune health, Kevin Caldwell’s journey is anything but conventional. In this episode of Biotech2050, Rahul Chaturvedi speaks with the CEO, Co-Founder & President of Ossium Health about how personal experiences with a reactive healthcare system—and a deep curiosity about the …

1
Leading the Pharmacy Automation Revolution with Omnicell Founder Randall Lipps 24:21

1M ago24:21

24:21

In this episode: Randy Lipps is Chairman, President, Chief Executive Officer, and Founder of Omnicell, a leader in transforming the pharmacy care delivery model. Under his leadership, Omnicell has grown from a single product offering to delivering the most comprehensive portfolio of medication management solutions across the continuum of care. Mr. …

1
Tailored Approach to Medication Access with Srulik Dvorsky 26:14

1M ago26:14

26:14

In this episode, our guest is Srulik Dvorsky, who is the co-founder and CEO of TailorMed. Drawing on his experiences caring for family members with cancer—and his background as a technological leader in the medical device space—he started TailorMed with a mission to remove barriers to care. Now the market’s category leader, TailorMed offers the nat…

1
Rewriting Cancer: AmirAli Talasaz, Co-CEO of Guardant Health, on Liquid Biopsy, Data & Biotech Grit 39:08

2M ago39:08

39:08

Synopsis: Some of the most game-changing ideas in healthcare come from unexpected intersections—where engineering meets biology, and where data meets patient urgency. This episode of Biotech 2050 dives into that exact convergence with a look at how one visionary leader helped pioneer blood-based cancer diagnostics.Co-CEO & Co-Founder of Guardant He…

1
Terns CEO Amy Burroughs on CML Innovation, Obesity Drug Breakthroughs & Leading Biotech Forward 22:55

2M ago22:55

22:55

Synopsis: Amy Burroughs, CEO of Terns Pharmaceuticals, joins Alok Tayi to share how she’s leading bold innovation in CML and obesity treatment, driving two high-stakes data readouts in 2025. From a non-linear path through tech, brand management, and Genentech to building resilient biotech teams, Amy reveals why product positioning, tolerability, an…

1
Jeremy Bender, Day One CEO, on Transforming Pediatric Cancer Care & Leading Biotech with Purpose 40:51

2M ago40:51

40:51

Synopsis: Host Rahul Chaturvedi sits down with Jeremy Bender, CEO of Day One Biopharmaceuticals, to explore the bold mission of transforming pediatric oncology. From earning FDA approval for a groundbreaking brain cancer drug to building a culture rooted in execution and empathy, Jeremy shares lessons from big pharma and startups alike. He discusse…

1
Modernizing Public Health Infrastructure with Dr. Heidi Steinecker 31:23

2M ago31:23

31:23

In this episode, our guest is Heidi Steinecker, DrPH & Principal of Health & Human Services Consulting at Resultant. With over two decades of leadership in public health and healthcare systems—including as Deputy Director of the California Department of Public Health—Heidi is helping states transform how they use data to prevent crises and protect …

1
Impact of AI on the future of our industry & software development 2:00:26

3M ago2:00:26

2:00:26

Thank you to HighByte for sponsoring this podcast: Learn more about the HighByte Intelligence Hub at https://www.highbyte.com Join us for the *MCP Workshop* on July 29-30, - https://www.iiot.university/courseBy Walker Reynolds & Zack Scriven

1
Ahmed Mousa, Vicore CEO, on IPF Breakthroughs, AI-Powered Drug Discovery & Global Biotech Leadership 16:33

3M ago16:33

16:33

Synopsis: What do courtroom litigation, computational biology, and fibrosis drug development have in common? In this episode of Biotech 2050, host Alok Tayi speaks with Ahmed Mousa, CEO of Vicore Pharma, to explore his unconventional journey from biotech law to the C-suite. Ahmed shares how Vicore is advancing a first-in-class therapy targeting the…

1
AI + Manufacturing: Behind the Scenes w/ Walker & Zack UNS Studio Reveal 1:26:20

3M ago1:26:20

1:26:20

In this episode, Walker Reynolds and Zack Scriven dive deep into the future of manufacturing with AI and give you a behind-the-scenes look at a powerful new product we’re building: UNS Studio. Thank you to HighByte for sponsoring this podcast: Learn more about the HighByte Intelligence Hub at https://www.highbyte.com Join us for the MCP Workshop on…

1
Curran Simpson, President & CEO of REGENXBIO, on Gene Therapy, Strategy & Patient-Centered Impact 28:19

3M ago28:19

28:19

Synopsis: When an introverted engineer becomes the President & CEO of REGENXBIO, transformation follows. Curran Simpson joins host Rahul Chaturvedi to unpack his unlikely journey from biotech operations to the C-suite—and how that hands-on experience is reshaping gene therapy's future.They dive into the evolution of REGENXBIO’s pipeline, tackling u…

1
Sergey Jakimov, Founding Partner at LongeVC, on Pragmatic Longevity Investing & Biotech Innovation 31:50

3M ago31:50

31:50

Synopsis: Longevity isn’t just about living longer—it’s about living better. In this insightful episode of Biotech 2050, host Alok Tayi sits down with Sergey Jakimov, Founding Partner at LongeVC, to unpack what it really takes to invest in the future of healthspan.Blending his experience as a medtech entrepreneur, rare disease patient, and venture …

1
Digital Mirrors & AI Agents: How Mark Freedman went on an AI Bender 1:14:54

3M ago1:14:54

1:14:54

Register for the MCP Workshop and save 40% signup using the code PODCAST40: https://www.iiot.university/offers/fagR6Ccz?coupon_code=PODCAST40 This Podcast is sponsored by HighByte. Learn more about their Data Ops platform here: https://www.highbyte.com In this exclusive Industry 4.0 Podcast episode, we sit down with visionary developer Mark Freedma…

1
Dr. Howard Fillit & Mark Roithmayr of ADDF on Alzheimer’s Innovation, Funding & Biomarkers 41:51

3M ago41:51

41:51

Synopsis:What happens when a world-class scientist and a philanthropic legacy collide with one of medicine’s greatest challenges? Dr. Howard Fillit and Mark Roithmayr of the Alzheimer’s Drug Discovery Foundation (ADDF) join host Alok Tayi for an inspiring conversation on bold science, visionary funding models, and the future of Alzheimer’s research…

1
Edge Connectivity Podcast w/ Phoenix Contact 1:02:04

3M ago1:02:04

1:02:04

By Walker Reynolds & Zack Scriven

1
The Future of PLC Programming and Integration: Unified Namespace 1:01:07

4M ago1:01:07

1:01:07

4.0 Podcast listeners, listen up! If your plant floor still speaks in mystery Modbus and legacy PLC grunts while leadership wants shiny AI dashboards, the Edge Connectivity → UNS Workshop—live online June 17‑19, 2025—is your shortcut. In three hands‑on sessions we’ll show you how to hook any asset, clean the data, and stream it straight into a Unif…

1
Stacy Lindborg, Imunon President & CEO, on Bold Biotech, IL-12 Immunotherapy & Phase 3 Trials 17:54

5M ago17:54

17:54

Synopsis: What does bold biotech leadership look like in 2025?In this episode of Biotech 2050, host Alok Tayi sits down with Stacy Lindborg, President & CEO of Imunon, to discuss bold innovation in ovarian cancer treatment and how harnessing the immune system through targeted gene therapy is reshaping survival outcomes.Stacy shares insights from he…

1
Stephanie Sirota, CBO & Partner at RTW Investments, on Biotech Investing, Policy & Bold Bet Building 24:48

5M ago24:48

24:48

Synopsis: What happens when a former journalist becomes one of biotech’s boldest investors? Meet Stephanie Sirota, Chief Business Officer and Partner at RTW Investments, who helped grow the firm from $27 million in assets to a global biotech force. In this engaging conversation with host Rahul Chaturvedi, Stephanie shares her unconventional path in…

1
Walker Reynolds isn't changing language for anyone.. and responding to LinkedIn Comments 48:54

5M ago48:54

48:54

Walker Reynolds is NOT changing for anyone... here's WHY Key Segments: Authenticity and Language Discussion on using authentic, colorful language in professional settings Defending use of occasional profanity as a communication tool Arguing that authentic communication respects the audience's intelligence Critique of Language Policing Responding to…

1
Unified Namespace and Community Updates Part 2/2 1:11:51

5M ago1:11:51

1:11:51

UNS and Community Updates Live Stream Episode Highlights: Hosts: Walker Reynolds and Zack Scriven Sponsor: Maintain X Duration: Approximately 2 hours 0:00-15:00: Podcast Introduction and Personal Updates Walker explains recent absence from content creation Discusses overwhelming number of messages and new communication strategy Personal updates: so…

1
Unified Namespace and Community Updates Part 1/2 1:19:31

5M ago1:19:31

1:19:31

UNS and Community Updates Live Stream Episode Highlights: Hosts: Walker Reynolds and Zack Scriven Sponsor: Maintain X Duration: Approximately 2 hours 0:00-15:00: Podcast Introduction and Personal Updates Walker explains recent absence from content creation Discusses overwhelming number of messages and new communication strategy Personal updates: so…

1
Bringing New Cancer Drugs to Market with Founder & CEO, Lewis Bender 34:53

6M ago34:53

34:53

In this episode, our guest is Lewis Bender, Chairman, and CEO, of Intensity Therapeutics’ Founder which is a late-stage clinical biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while …

1
Steve Tregay on Leading Mission BioCapital as Managing Partner & Fueling Early-Stage Biotech 41:54

6M ago41:54

41:54

Synopsis: Building in biotech isn’t for the faint of heart—especially during a market downturn. But that’s exactly when Steve Tregay, Managing Partner at Mission BioCapital, thrives. A seasoned entrepreneur and founder of Forma Therapeutics, Steven has navigated biotech’s toughest cycles—and emerged stronger each time.Hosted by Rahul Chaturvedi, th…

1
Handling the Intersection of Faith and Work with Dean Tom Campbell 27:06

6M ago27:06

27:06

In this episode, our guest is Tom Campbell, the Dean and Associate Professor of Pharmacy Practice at Lipscomb University College of Pharmacy in Nashville. Dr. Campbell received his Pharm.D. degree from the University of Tennessee College of Pharmacy and received board certification in pharmacotherapy in 1995. His prior work experience includes a ph…

1
Neil F. McFarlane, President & CEO of Zevra Therapeutics, on Leading Rare Disease Innovation 35:35

6M ago35:35

35:35

Synopsis: In this episode of Biotech2050, host Rahul Chaturvedi sits down with Neil F. McFarlane, President and CEO of Zevra Therapeutics, to explore his unique leadership journey from military nurse to biotech executive. Neil shares reflections from his time at Genzyme and UCB, insights on running a rare disease-focused biotech, and the art of mis…

1
Telehealth: A Comprehensive Guide for Pharmacies with Arielle Miliambro 33:18

6M ago33:18

33:18

In this episode, our guest is Arielle Miliambro, a Partner specializing in regulatory and transactional law within the Healthcare & Life Sciences departments. She assists clients with legal issues related to telehealth, data privacy, value-based care, and fraud compliance. She offers counsel on regulations like the Anti-Kickback Statute and prepare…

1
Raj Devraj, President & CEO - Rectify Pharma, on Drug Discovery, Biotech Breakthroughs & Growth 34:03

6M ago34:03

34:03

Synopsis: How do you build a biotech company that disrupts drug discovery and delivers real impact? In this episode of Biotech 2050, host Rahul Chaturvedi speaks with Raj Devraj, President & CEO of Rectify Pharmaceuticals and Venture Partner at Atlas Venture.Raj shares his journey from big pharma to biotech entrepreneurship, the science behind Rect…

1
Expanding digital transformation fluency 1:44:30

6M ago1:44:30

1:44:30

Zack Scriven and Walker Reynolds discuss how to expand your digital transformation fluency.By Walker Reynolds & Zack Scriven

1
Revolutionizing CAR T with CRISPR: Rachel Haurwitz, President & CEO of Caribou Biosciences 26:25

7M ago26:25

26:25

Synopsis: Host Rahul Chaturvedi welcomes back Rachel Haurwitz, President & CEO of Caribou Biosciences, for a deep dive into the future of CRISPR-based genome editing and its transformative impact on cell therapy. As a pioneer in the field, Rachel shares the evolution of off-the-shelf CAR T therapies and how Caribou Biosciences is tackling some of t…

1
Liam Killingstad on How Family Offices Quietly Fuel Biotech’s Boldest Innovations 59:19

7M ago59:19

59:19

Synopsis: In this thought-provoking episode of Biotech 2050, host Alok Tayi sits down with Liam Killingstad, Member at Finiam Investments, to unpack the growing influence of family offices in biotech. Driven by his own family's experience with rare cancers, Liam shares how that journey sparked Finiam's deep dive into biotech investing and the co-cr…

1
ProveIt! Conference 2025 - Reactions Podcast 1:48:39

7M ago1:48:39

1:48:39

Zack and Walker talk about their thoughts following the ProveIt! conference including what vendors they were the most impressed with!By Walker Reynolds & Zack Scriven

1
Clare Terlouw, Head of LifeArc Ventures, on Bridging Biotech’s Funding Gap & Investing for Impact 42:53

7M ago42:53

42:53

Synopsis: Host Alok Tayi sits down with Clare Terlouw, Head of Ventures at LifeArc Ventures, to explore biotech investing from an LP perspective. Clare shares her unique journey—from physiotherapy to investment banking and, ultimately, leading venture investments at a medical charity. The conversation delves into LifeArc’s role in bridging the fund…

1
A Guide To Navigating Health Plans and Fixing American Health Insurance with Mark Ryan 29:30

7M ago29:30

29:30

In this episode, Our guest is MARC RYAN, who has extensive leadership experience across the healthcare industry. Most recently, he was a founding executive and President of MedHOK (MHK, acquired by Hearst Health). He has launched and operated multiple health plans. Marc served in senior policy roles in state and federal government, including as sta…

1
AI, Biotech, & Venture Capital: Alex Bangash, Founder of Transpose, on Future of Startup Investing 23:49

7M ago23:49

23:49

Synopsis: Venture capital is evolving, and so is biotech. In this episode of Biotech 2050, host Alok Tayi, CEO and co-founder of VibeBio, sits down with Alex Bangash, Founder of Transpose, an investment firm backing both startups and funds.With over 20 years of experience in venture investing, Alex shares his unconventional journey from engineering…

1
Real Estate Pulse FT. Austin Marks 47:26

8M ago47:26

47:26

Unlock the secrets of navigating Florida's shifting real estate climate with our special guest, Austin, a seasoned real estate professional. We promise to provide you with valuable insights into the latest trends and challenges in the market, from the impact of the NAR settlement on commission fees to the evolving preferences of homebuyers in flood…

1
ProveIt! Conference 2025 - Final Podcast before the show! 2:07:35

8M ago2:07:35

2:07:35

Final Podcast before the conference! We go over schedule, hot takes on all the vendor sponsors, and Walker shares a vulnerable update. don't want to miss this one!By Walker Reynolds & Zack Scriven

1
Empowering Neurodivergent Innovators: Chad Belinsky on Impact, Mentorship, and Atypical Path 35:35

8M ago35:35

35:35

Synopsis: In this special episode of Biotech 2050, Host Alok Tayi, CEO and Co-Founder of VibeBio, delves into the world of neurodivergent entrepreneurship and impact investing with guest Chad Belinsky, founder of AtypicalPath.org. Chad shares his inspiring journey from running a transformative B2B materials company to establishing Atypical Path—a n…

1
Biotech Venture Investing with Narayan Chowdhury, Co-Founder of Franklin Park LLC 27:32

8M ago27:32

27:32

Synopsis: In this episode of Biotech 2050, host Alok Tayi explores the world of biotech venture capital with Narayan Chowdhury, Co-Founder of Franklin Park. As a key player in funding the next wave of biotech breakthroughs, Narayan shares how limited partners (LPs) navigate risk, identify high-potential biotech funds, and decide where to allocate b…

1
Unlocking Mental Wellness FT. Francesca Cook 1:10:08

8M ago1:10:08

1:10:08

Unlock the secrets of mental wellness with Francesca Cook, the insightful founder of Replenish Counseling LLC. Join us as we unravel the threads of mental health therapies, focusing on unique approaches like play therapy and sand tray therapy, which allow individuals to communicate their deepest emotions without words. Francesca sheds light on acce…

1
David Meeker, CEO of Rhythm Pharmaceuticals, on Rare Disease Breakthroughs & Biotech’s Future 58:17

8M ago58:17

58:17

Synopsis: Join host Alok Tayi as he welcomes David Meeker, CEO of Rhythm Pharmaceuticals, for an inspiring conversation on the transformative journey of rare disease biotech. David shares his incredible path from practicing physician to biotech visionary, recounting his experiences at Genzyme, where he helped shape the rare disease business model a…

1
Overcoming Career Transitions and Adversity FT. Tim Meyer 1:08:00

9M ago1:08:00

1:08:00

Tim Meyer, a seasoned expert in the sports industry, joins us to share his deeply personal journey through career transitions and the unforeseen challenges of unemployment. From orchestrating monumental events like the Junior Olympics to navigating the emotional and financial trials after losing his job at AAU, Tim offers a candid reflection on the…

1
AI in Manufacturing - Industry 4.0 Live Q&A - Jan 3, 2025 1:56:27

9M ago1:56:27

1:56:27

In this episode of the 4.0 Solutions Podcast, Walker Reynolds and Zack Scriven take a deep dive into the evolving landscape of Industry 4.0. From AI's transformative impact to behind-the-scenes insights on the upcoming ProveIt Conference, this discussion is packed with valuable takeaways. Learn about the mistakes vendors are making, uncover strateg…

1
Ep 53 New Years Recap 50:16

9M ago50:16

50:16

In this podcast, we reflect on the lessons learned from 2024, revisiting the aspirations and goals we discussed at the year's start. Our conversation covers personal milestones, accountability for missed targets, and the importance of friendship in navigating challenges while looking ahead to set meaningful intentions for 2025. • Overview of 2024 a…

1
MES Bootcamp Webinar: Building the Core of Manufacturing Execution 1:47:13

10M ago1:47:13

1:47:13

Dive into the world of Manufacturing Execution Systems (MES) with this special MES Bootcamp Webinar. Join Walker Reynolds and Zack Scriven as they explore: What MES truly is and why "MES is not MES." The Core Four Features every MES system needs and how they drive operational excellence. Real-world examples of MES implementations, from tracking dow…

1
Industry 4.0 Podcast: The Most Common 3 Questions we get 1:17:30

10M ago1:17:30

1:17:30

In this episode, Walker Reynolds and Zack Scriven tackle the three most common questions they receive from the Industry 4.0 community. From choosing the right technology to implementing a Unified Namespace and navigating digital transformation strategies, they provide actionable insights and clear answers to help you on your journey. If you're look…

1
Empowering Pharmacy Leaders: Practical Steps for Enhancing Team Performance with Laurie Lee Smith 21:54

10M ago21:54

21:54

In this episode, our guest is Laurie Lee Smith, who is the CEO of Laurie Lee Leadership and a seasoned executive coach with over three decades of healthcare expertise, certified by the International Coaching Federation (ICF). Laurie’s international coaching and leadership engagements have spanned continents, including North America, the Middle East…

1
Shedding Light on Rare Diseases with Tamar Thompson 23:04

10M ago23:04

23:04

In this episode, our guest, Tamar (Tay-mar) Thompson with us, the Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. With over 20 years of experience in healthcare, Tamar leads global corporate efforts in policy and advocacy. She recently has been showcasing Alexion’s new short film, Rare Connections in NMOSD where she underscores the …

1
Pioneering Advances in Cell Therapy: Kristin Yarema, President & CEO of Poseida Therapeutics 38:57

10M ago38:57

38:57

Synopsis: Host Rahul Chaturvedi leads an insightful conversation with Dr. Kristin Yarema, President and CEO of Poseida Therapeutics. Kristin shares the inspiring journey of her career, from her roots in science to leadership roles in big pharma, culminating in her move to biotech entrepreneurship. She reflects on pivotal experiences at Novartis and…

1
The Passion Project FT. Joey Casolaro 59:29

11M ago59:29

59:29

Unlock the secrets to financial empowerment with Joey Casolaro, an Associate Advisor at Highland Financial Advisors LLC, as he shares practical insights and strategies designed to elevate your financial journey. Discover why budgeting isn't about limiting yourself, but rather a crucial tool for gaining control over your cash flow and setting the gr…